美国海关因FDA问题扣货？如何顺利放行？—— 紧急应对与“通关谈判”全策略

Core Insights - The article emphasizes the importance of remaining calm and taking swift action when goods are detained by U.S. Customs due to FDA issues, highlighting that proper responses can lead to successful release of the goods [1][3]. Group 1: Understanding Detention Notices - The first step is to decode the "detention notice," which is a formal document that outlines the reasons for the detention and serves as a guide for action [2]. - Common reasons for detention include "unregistered facilities," "labeling issues," "sampling requirements," and "suspected unapproved ingredients," each requiring different responses [5]. Group 2: Response Strategies - Four strategies are recommended based on the reason for detention: - Immediate correction for document or labeling errors, which is the ideal scenario [7]. - A fundamental approach for unregistered facilities, which involves initiating FDA registration and potentially negotiating for a grace period [9]. - Physical remediation or transfer for correctable issues, allowing for rectification at an approved third-party warehouse [8]. - Decisive loss mitigation through re-exportation or destruction if the product cannot meet FDA requirements [10]. Group 3: Utilizing Professional Resources - Engaging professional FDA customs brokers or lawyers is strongly advised to navigate the complexities of FDA regulations and improve the chances of successful resolution [11]. - Caution is advised against any freight forwarder claiming guaranteed clearance, as reputable service providers will assess compliance risks realistically [11].